Androgen-regulated and highly tumorigenic human prostate cancer cell line established from a transplantable primary CWR22 tumor.
about
P1343
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancerOvercoming mutation-based resistance to antiandrogens with rational drug designAR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progressionAnnotating STEAP1 regulation in prostate cancer with 89Zr immuno-PETPharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer.Therapeutic targeting of SPINK1-positive prostate cancer.Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate CancerSrc controls castration recurrence of CWR22 prostate cancer xenografts.SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.Exosome-mediated Transfer of αvβ3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype.Characterization of fibroblast-free CWR-R1ca castration-recurrent prostate cancer cell line.Testosterone and prolactin increase carboxypeptidase-D and nitric oxide levels to promote survival of prostate cancer cells.Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression.SOX2 expression in the developing, adult, as well as, diseased prostateSTAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair.
P2860
Q26777310-9C38071C-B1F4-419D-9D72-AF227998FFCBQ28044590-49D716E5-D5E6-4BA7-9867-21DA80E52C8CQ30513836-0AC506BC-687D-444A-9393-EFA7DAC6C770Q30643770-05F973BB-5643-4C5C-8ACF-C810F3EA212FQ34363785-6E0B708D-A243-4904-B0BB-247933EE5189Q35536144-DDB8712F-B2BE-4CD1-9B36-683D1E19CFF1Q36134471-FE3DC2F9-5B41-4A6D-9E19-2D8CE533618BQ37481145-0CE4F70A-BA2F-4A11-8251-24FDD71BE18AQ37595372-BE865D81-B2FF-418F-A562-965CA94A61B6Q38385340-67A9E921-0CE6-481E-82F1-2844FA82E5BFQ38756785-06EDF950-EC20-4824-ADD3-427455741AFFQ38766081-426D79FC-044F-462E-8D68-55D5673E8429Q39521501-175A7D2A-A797-4F0D-9227-802AE52B0BF2Q39605639-017800C1-88BE-4043-9F43-709D82934992Q42463444-0FBC5CFC-3767-489A-B25C-B9D3DDEC84EEQ52684496-63508195-79D1-4CCE-A952-9ADD3CBB8ABC
P2860
Androgen-regulated and highly tumorigenic human prostate cancer cell line established from a transplantable primary CWR22 tumor.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Androgen-regulated and highly ...... plantable primary CWR22 tumor.
@en
type
label
Androgen-regulated and highly ...... plantable primary CWR22 tumor.
@en
prefLabel
Androgen-regulated and highly ...... plantable primary CWR22 tumor.
@en
P2093
P2860
P1476
Androgen-regulated and highly ...... splantable primary CWR22 tumor
@en
P2093
Ayush Dagvadorj
Bassem R Haddad
Luciane R Cavalli
Marja T Nevalainen
Zhiyong Liao
P2860
P304
P356
10.1158/1078-0432.CCR-08-0979
P407
P4510
P50
P577
2008-10-01T00:00:00Z